Spectrum of Anti‐Neurofascin Neuropathies: A Retrospective Indian Cohort

Anti-Nf-associated neuropathies in this Indian cohort were clinically heterogeneous, spanning acute, chronic, and recurrent phenotypes. Tremors, sensory ataxia, pain, and fulminant onset are valuable diagnostic clues. Pan-Nf-associated neuropathies were consistently severe and treatment-resistant. Rituximab demonstrated significant benefit in most cases, supporting its use in refractory and relapsing disease.